Showing 2271-2280 of 2735 results for "".
- New Scope of Practice Guidelines and Other Legal Changes: Are You Up to Speed?https://modernaesthetics.com/news/new-scope-of-practice-guidelines-and-other-legal-changes-are-you-in-compliance/2473465/Summer vacation is good for relaxing and taking a bit of a break from the daily grind, but it is also a great time to get up to speed on changing regulations that may impact the services your practice provides and who performs those services. For example, recently, in New York State (&l
- BeautyHealth and LaserAway Expand Partnershiphttps://modernaesthetics.com/news/beautyhealth-and-laseraway-expand-partnership/2473464/The Beauty Health Company will supply Hydrafacial Syndeo devices to LaserAway’s locations across the U.S. and any new practice sites opened through 2025. Syndeo combines Hydrafacial’s patented vortex fusion technology with a digital experience. Using Syndeo’s con
- Summer Slump? Use Your Free Time to Get Aheadhttps://modernaesthetics.com/news/summer-slump-use-your-free-time-to-get-ahead/2473463/Summer is notoriously slow for many aesthetic practices. instead of becoming distraught over the lower volume, use the slower times to get ahead of the fall and winter rush, says Jay A. Shorr BA, MBM-C, CAC I-XVI, founder and managing partner of Shorr Solutions in Coral Springs, Fla.
- Nulastin Taps Felipe Jimenez, PhD, for Chief Science Officerhttps://modernaesthetics.com/news/nulastin-taps-felipe-jimenez-phd-for-chief-science-officer/2473462/Felipe Jimenez, PhD, is Nulastin’s new Chief Science Officer. Formerly of Benchmark Cosmetic Laboratories (a KDC/One company) and Guthy-Renker, Mr. Jimenez holds more than 30 patents on elastin regeneration. "This is a dream come true having F
- SK-II Introduces Pitera Expert Panelhttps://modernaesthetics.com/news/sk-ii-introduces-pitera-expert-panel/2473450/SK-II’s PITERA may reduce the Aging Trigger Factor (AT-0), potentially slowing skin aging, according to research presented at the World Congress of Dermatology 2023 in Singapore. AT-0 accelerates signs of aging via a chain reaction, even as early as i
- Venus Concept Introduces Medical Advisory Board for AI.MEhttps://modernaesthetics.com/news/venus-concept-introduces-medical-advisory-board-for-aime/2473449/The primary mission of the medical advisory board will be to provide strategic input, guidance, and clinical recommendations regarding the Company's emerging robotic technology, AI.ME, which received its first 510(k) clearance from the U.S. Food and Drug Administration (FDA) in December 2022,
- Acclaro Medical Rolls Our Rebranded UltraClear Cold Fiber Laserhttps://modernaesthetics.com/news/acclaro-medical-rolls-our-rebranded-ultraclear-cold-fiber-laser/2473448/Meet the newly re-branded UltraClear Cold Fiber Laser from Acclaro Medical. From a design perspective, rebranding encompasses an updated logo and color palette and aims to increase recognition of UltraClear's 3DIntelliPulse technology and its ability to provide optima
- What is Exosome Therapy? All Your Questions Answeredhttps://modernaesthetics.com/news/what-is-exosome-therapy-all-your-questions-answered/2473445/Exosomes are among today’s buzziest skincare ingredients, but what exactly are exosomes, how can you choose the best product to recommend to patients, and how can exosomes be used to complement in-office skin rejuvenation procedures? New York City dermatologist Marina I. Pere
- Hairy Moles May Hold the Secret to Understanding Hair Growthhttps://modernaesthetics.com/news/hairy-moles-may-hold-the-secret-to-understanding-hair-growth/2473434/Do hairy moles hold the secret to understanding hair growth? Maybe, according to research published in the June 21, 2023 issue of Nature. Using a mouse model, researchers tracked the activit
- Xeomin Performs Well in Phase 3 Studies of Upper Facial Lineshttps://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as